Growth Metrics

Dolby Laboratories (DLB) Receivables - Other (2018 - 2025)

Dolby Laboratories' Receivables - Other history spans 8 years, with the latest figure at $198.3 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 13.29% year-over-year to $198.3 million; the TTM value through Dec 2025 reached $198.3 million, up 13.29%, while the annual FY2025 figure was $180.8 million, 4.03% up from the prior year.
  • Receivables - Other reached $198.3 million in Q4 2025 per DLB's latest filing, up from $180.8 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $275.3 million in Q1 2023 to a low of $106.9 million in Q3 2022.
  • Average Receivables - Other over 5 years is $192.4 million, with a median of $191.7 million recorded in 2023.
  • Peak YoY movement for Receivables - Other: surged 193.58% in 2021, then plummeted 45.14% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $226.8 million in 2021, then fell by 4.8% to $215.9 million in 2022, then grew by 0.76% to $217.6 million in 2023, then decreased by 19.56% to $175.0 million in 2024, then increased by 13.29% to $198.3 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Receivables - Other are $198.3 million (Q4 2025), $180.8 million (Q3 2025), and $204.4 million (Q2 2025).